ArticleLeukemia2015

Deoxycytidine-kinase knockdown as a novel myeloprotective strategy in the context of fludarabine, cytarabine or cladribine therapy.

N Lachmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.